EPA for Metastasis Trial 2

Clinical trial NCT03428477 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03428477
Sponsor: Mark A Hull, PhD FRCP
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Liver Metastasis Colon Cancer

Start date: 2018-05-02
Primary completion: 2025-11-30
Enrollment: 418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.